DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells. by Hejmadi, M. V. et al.
British Journal of Cancer (1996) 73, 499-505
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 9
DNA damage following combination ofradiation with the bioreductive drug
AQ4N: possible selective toxicity to oxic and hypoxic tumour cells
MV Hejmadil, SR McKeown', OP Frieryl, IA McIntyre', LH Patterson2 and DG Hirst'
'School ofBiomedical Sciences, University of Ulster at Jordanstown, N. Ireland BT37 OQB; 2Department ofPharmaceutical
Sciences, De Montfort University, Leicester LEI 9BH, UK.
Summary AQ4N (1,4-bis-{[2-(dimethylamino-N-oxide)ethyl]amino}5,8-dihydroxyanthracene-9,10-dione) is a
novel bioreductive agent that can be reduced to a stable, DNA-affinic compound, AQ4. The alkaline comet
assay was used to evaluate DNA damage induced by AQ4N and radiation. Cells prepared from freshly excised
T50/80 murine tumours were shown to have the ability to reduce AQ4N to a DNA-damaging agent; this had
disappeared within 24 h of excision. When T50/80 tumours implanted in BDF mice were exposed to radiation
in vivo a considerable amount of DNA damage was present in tumours excised immediately. Minimal levels of
DNA damage were detectable in tumours excised after 2-5 h. AQ4N given 30 min before radiation had no
appreciable influence on this effect and AQ4N alone caused only a small amount of damage. When AQ4N and
radiation were combined an increasing number of damaged cells were seen in tumours excised 24-96 h after
irradiation. This was interpreted as evidence ofthe continued presence ofAQ4, or AQ4-induced damage, which
was formed in cells hypoxic at the time of administration of AQ4N. AQ4, a potent topoisomerase II inhibitor,
would be capable of damaging cells recruited into the cell cycle following radiation damage to the well-
oxygenated cells of the tumour. The kinetics of the expression of the DNA damage is consistent with this
hypothesis and shows that AQ4 has persistent activity in vivo.
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The presence of hypoxic cells within tumours is thought to be
a major cause of treatment failure following radiotherapy
(Bush et al., 1978; Okunieff et al., 1993). Bioreductive drugs
specifically target these radioresistant cells since they are
administered as a non-toxic prodrug that is reduced in a low-
oxygen environment to an active cytotoxic product (Work-
man and Stratford, 1993). We have developed a novel
compound AQ4N (1,4 - bis - {[2 -(dimethylamino -N - oxide)-
ethyl]amino}5,8-dihydroxyanthracene-9,10-dione), which can
be reduced in a hypoxic environment to a stable DNA-affinic
agent AQ4 (1,4-bis-{[2-(dimethylamino)ethyl}amino}5,8-dihy-
droxyanthracene-9,10-dione). Reduction of the two N-oxide
side chains of the electrically neutral AQ4N leads to the
formation of two positively charged alkylamino side chains
(Figure 1). These interact electrostatically with DNA,
resulting in a highly significant level of AQ4 binding
(Patterson, 1993) and account for several distinct differences
in the properties of AQ4 as compared with AQ4N (Table I).
It should be noted that AQ4 is a structural analogue of the
cancer chemotherapeutic agent mitoxantrone, which has been
shown to have a high affinity for DNA. Both compounds are
also known to inhibit topoisomerase II (Patterson, 1993;
Desnoyes et al., 1993).
In the present study, we have used the alkaline single cell
gel electrophoresis assay (comet assay) to evaluate DNA
damage in T50/80 tumour cells exposed to AQ4N in vivo and
ex vivo. The alkaline comet assay, based on the method of
Singh et al. (1988), is used to detect single-strand breaks in
DNA following disruption of the DNA by exposure to high
pH. During electrophoresis the broken/unwound DNA
streams away from the undamaged DNA and is observed
as a 'comet' tail. Unlike other assays (Whitaker et al., 1991),
the comet assay allows the detection and quantitation of
DNA damage in individual cells. It has been used in a variety
of situations to measure DNA damage and repair
(McKelvey-Martin et al., 1993; Olive, 1994), with a
sensitivity greater than or equal to other methods that are
currently available (Olive et al., 1990).
Our earlier studies with T50/80 tumour-bearing mice have
shown that AQ4N (200 mg kg-1) significantly enhanced the
tumour growth delay caused by radiation. This occurred
when radiation was administered both as a single dose
(12 Gy) and in a multifraction regimen (5 x 3 Gy). A study of
the scheduling of AQ4N administration showed that there
was a very long time period over which a maximal effect
could be elicited (drug given 4 days before to 6 h after
radiation). These results suggest that AQ4N has significant
potential as a bioreductive drug (McKeown et al., 1995). In
the present study the comet assay was used to evaluate in
more detail the mechanism of these interactions.
Materials and methods
Tumour model
These experiments were carried out using early passages (4-
14) of the poorly differentiated T50/80 murine mammary
carcinoma. This first arose in a female BDF mouse mammary
gland; details of the derivation and maintenance have been
published previously (Moore, 1988). Tumours were induced
on the rear dorsum of 8- to 12-week-old male B6D2F1 mice
using 0.05 ml of tumour brei prepared from a donor mouse.
Ex vivo protocol
Untreated T50/80 tumours (6.5-9.0 mm geometric diameter,
GMD) were excised and gently disaggregated by mechanical
disruption in ice-cold phosphate-buffered saline (PBS). Single
cell suspensions were prepared by filtration through a 40 gum
mesh. These were then centrifuged and resuspended in
Eagle's minimal essential medium (EMEM) containing 10%
fetal calf serum (FCS) at a concentration of 106 cells ml-'.
Cells (20 ml) were placed in 125 ml rubber sealed glass
bottles. These were gassed for 2 h at 37°C to provide well-
oxygenated conditions, i.e. 95% air/5% carbon dioxide or
hypoxic conditions 95% nitrogen/5% carbon dioxide. AQ4N
(20 gM) was added for the last 90 min of this period by
injection through the sealed lid. Drug was washed off and
cells resuspended in fresh medium. For analysis of DNA
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damage, aliquots (10' cells) were processed at various times
ranging from 0 to 96 h after this procedure. To evaluate the
effect of maintaining the excised tumour cells in culture,
samples were also maintained in the culture medium above at
37°C, 95% air/5% carbon dioxide for 24 h. The cells, which
grow in suspension, were then harvested and placed in glass
bottles and the experiment outlined above was carried out.
Each experiment was carried out twice and the results pooled.
a
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Figure 1 The chemical structure of the alkylaminoanthraquinone
N-oxide AQ4N and its four-electron reduction product AQ4. This
requires four electrons overall, in which each N-oxide moiety
independently undergoes two-electron reduction.
In vivo protocol
These experiments were carried out when tumours reached a
GMD of 6.5 -9.0 mm. AQ4N was administered as a single
i.p. injection at a dose of 200 mg kg-'. The drug was given
30 min before a single dose of X-irradiation of 12 Gy
(300 kVp Siemens Stabilipan with a dose rate of
2.56 Gy min-'). Tumours were excised at a range of times
following treatment and placed on ice. Single cell suspensions
were prepared in ice-cold PBS as outlined above. Following
centrifugation the cells were diluted in cold EMEM contain-
ing 10% FCS (1 x 106 cells ml-1). An aliquot of 100 ,ul of this
suspension was used in the comet assay. This procedure was
carried out on tumours excised at various time intervals
ranging from 0 to 120 h following irradiation. The results are
pooled from three individual experiments.
Comet assay protocol
The alkaline single cell gel electrophoresis assay (Singh et
al., 1988) was used to assess DNA damage in individual
cells. Fully frosted microscope slides (Labcraft Dakin) were
coated with 100 yl of normal agarose (Sigma) and allowed
to solidify under a coverslip on ice for 5 min. Cells were
washed and resuspended in 10 jl of ice-cold PBS. An
aliquot of 100 ,l of low melting point agarose (Sigma type
VII) was added to the cells, gently mixed and pipetted on
top of the first layer of agarose. This was allowed to
harden before the third layer of type VII agarose was
pipetted on to the slide (100 MI). After gelling, slides were
immersed in a lysing solution consisting of 2.5 M sodium
chloride, 100 mM Na2EDTA, 10 mM Tris, 1% Triton X-100
and 10% dimethyl sulphoxide (DMSO) at 4°C in the dark
for at least 1 h. Slides were then placed in electrophoresis
buffer (300 mM sodium hydroxide, 1 mM Na2EDTA at
pH> 13) for 20 min. Horizontal gel electrophoresis was
performed in a fresh solution of the buffer for 20 min at
0.83 V cm-1 (25 V, 300 mA). Slides were then washed twice
in neutralisation buffer (0.4 M Tris, pH 7.5) to remove
alkali and detergents. Slides were stained with 40 ,l of
ethidium bromide (20 ,ug ml-') and analysed within 48 h.
Comets were analysed under a 40 x objective using an
Olympus BH-2 epifluorescence microscope equipped with a
100 W mercury power source, a 515-560 nm excitation
filter and a 590 nm barrier filter. The microscope was
attached to a Pulnix MT 765 intensified camera and a
Hewlett Packard PC 486/33U. DNA migration was
quantified using a Matrox image processing and analysis
package from Kinetic Imaging, UK (Comet v 2.2). DNA
damage was assessed using the tail moment parameter,
which is defined as the product of the percentage of DNA
in the tail (per cent fluorescence intensity in the tail) and
the tail length. Tail moment (TM) was found to be the
most reliable indicator for measuring DNA damage
(McKelvey-Martin et al., 1993).
Table 1 A summary of the properties of AQ4N and its reduction product AQ4
Property Prodrug: AQ4N Reduction product: AQ4
Planar molecule Yes Yes
Side chains N-oxide (2) Alkyl amino group (2)
Charge Neutral Positive
Binding constant for DNAa No binding detected 3.3 x 106 (M-1)
Topoisomerase 11 inhibition (drug > 50 gM 2 gM
required for total block)a
Cytotoxicity to V79a
In air Very low High
In hypoxia Small increase High
Hypoxia +microsomes High High
Dose enhancement ratio in vivob 5.1 Not determined
Elimination half-life in miceC 30 min Several hours?
This table highlights the differences in some ofthe critical properties ofAQ4N and AQ4. The information has been collated
from several sources: aPatterson (1993); bMcAleer et al. (1992); CM Graham and LH Patterson, personal communication.
$0Results
The effect ofAQ4N on cells from excised T50/80 tumours
exposed to drug ex vivo
This experiment was designed to assess the ability of T50/80
cells to metabolise AQ4N to a cytotoxic product ex vivo.
Untreated T50/80 tumours were made into single cell
suspensions and exposed to 20% or 0% oxygen with or
without AQ4N (20 gM) (Figure 2). The T50/80 tumour cells
maintained under aerobic conditions showed no DNA
a
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damage at any of the time periods studied (Figure 2a).
When AQ4N was present under aerobic conditions a very
small number of cells showed damage. This was only
observed at relatively long times after exposure to drug
(24-96 h) (Figure 2b). Under hypoxic conditions almost no
DNA damage was observed in the absence of AQ4N,
although a very small number did show severe damage at
longer intervals after hypoxic exposure (Figure 2c). When
cells were exposed to AQ4N with hypoxia an increasing level
of DNA damage was observed from 24 to 96 h. By 96 h
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Figure 2 Frequency plots showing the extent of DNA damage in individual cells prepared from excised T50/80 tumours. Single cell
suspensions, prepared from freshly excised tumours, were placed in glass flasks and gassed for 30min under oxic (95% air/5%
carbon dioxide) or hypoxic (95% nitrogen/5% carbon dioxide) conditions. This was carried out for a further 90min with or without
AQ4N (20 Mm). Cells were then washed free of drug in ice-cold PBS and incubated under 95% air/5% carbon dioxide at 37°C for 0
to 96h. DNA damage was assessed in aliquots of cells removed from these suspensions. Frequency plots show the number of cells
grouped by tail moment (see Materials and methods). Experimental conditions investigated were (a) oxic, (b) oxic+AQ4N, (c)
hypoxic and (d) hypoxic+AQ4N.
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almost all cells analysed had some damage, with many being
severely damaged (Figure 2d). This suggests that the T50/80
tumour can metabolise AQ4N to a cytotoxic compound,
which may be AQ4 (see Figure 1). If the tumour cells were
maintained under normal tissue culture conditions for 24 h
before exposure to AQ4N and hypoxia no DNA damage was
observed at any time after exposure (Figure 3a-d). This
occurred even though AQ4N was known to be taken up by
the cells. AQ4N is an intense blue colour and cells exposed to
all treatments showed blue staining when exposed to the
drug. (This occurred in experiments when the exposure to
hypoxia was at 0 h or 24 h).
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The effect of AQ4N and radiation on T50/80 tumours treated
in vivo
This protocol was designed to evaluate the time course of
DNA damage produced in tumours in vivo following
radiation exposure in the presence of AQ4N. Our earlier in
vivo studies had shown an enhanced anti-tumour effect when
AQ4N (200 mg kg-') was administered in combination with
radiation (12 Gy), (McKeown et al., 1995). Figure 4 shows
DNA damage expressed as tail moment following a range of
treatments. Tumours subjected to no treatment showed no
DNA damage at any of the time points studied (Figure 4a).
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Figure 3 Frequency plots showing the extent ofDNA damage in individual cells prepared from excised T50/80 tumours maintained
in vitro for 24h. Cells prepared from excised tumours were maintained under standard tissue culture conditions before carrying out
the experiment as detailed in Figure 3, except that cells were tested only up to 72h after treatments. Experimental conditions
investigated were (a) oxic, (b) oxic +AQ4N, (c) hypoxic and (d) hypoxic+AQ4N.AQ4N alone had only a small effect on the tumour at all time
points studied (Figure 4b). Exposure to radiation alone
resulted in a large number of cells showing severe levels of
damage, i.e. high tail moments at time zero. By 5 h the
percentage of damaged cells had been reduced to almost
background levels with most of the cells showing 0-5% TM.
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This reduction in damage was observed until at least 96 h,
although at all times there were a few cells showing damage
(<5% of all cells examined; Figure 4c). If AQ4N was
administered before radiation this had no appreciable effect
on the extent and time course of DNA damage for up to
18 h, when compared with radiation administered alone.
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Figure 4 Frequency plots showing the extent of DNA damage in cells prepared from T50/80 tumours excised from BDF mice.
Before excision the tumours were exposed to one of a range of treatments when the tumours reached a size of 6.5-9mm geometric
mean diameter. (a) No treatment. (b) A single i.p. injection ofAQ4N (200mgkg -'). (c) A single dose ofX-irradiation (12Gy). (d) A
single dose ofAQ4N (200mgkg 1) 30min before a single dose ofX-irradiation (12Gy). On excision at a range of times (see figures)
after treatment, single cell suspensions were prepared by gentle mechanical disaggregation and the cells were analysed using the
alkaline comet assay. DNA damage in individual cells is shown using frequency plots of the number ofcells grouped by tail moment
(see Materials and methods).
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However by 24 h the proportion of damaged cells had begun
to increase and this became more extensive by 72-120 h
following exposure to radiation. By this time many of the
cells showed moderate to severe DNA damage, whereas
tumours exposed to radiation alone had only low levels of
severely damaged cells at these later time points.
Discussion
AQ4N can be reduced to AQ4 by exogenous liver
microsomes but is poorly reduced by several established cell
lines (Patterson, 1993, 1994). It is proposed that the
insensitivity of in vitro cells may be due to a lack of the
appropriate enzyme(s) necessary for the reduction of AQ4N,
since reduction does occur when freshly prepared liver
microsomes are present. This does not exclude the possibility
that AQ4N is reduced in vivo, since it is well recognised that
enzyme profiles change when cells are transferred to a tissue
culture environment (Collard et al., 1985; Krupski et al.,
1985). Studies in a range of murine models (Cole, private
communication; McKeown et al., 1995) would support the
proposition that AQ4N is metabolised in vivo to a cytotoxic
compound. The current series of studies was designed to
further explore this hypothesis.
Initially we used excised T50/80 tumour cell suspensions
and examined their ability to metabolise AQ4N under
hypoxic conditions in vitro (Figure 2a-d). Our results show
that AQ4N remained almost completely inactive under oxic
conditions despite being taken up into the cells. Under
hypoxic conditions, AQ4N was modified to a DNA-
damaging agent, which had increasing effectiveness from
24 h after the initial exposure. It is suggested that the
cytotoxic agent formed is AQ4, since this is the only known
reduction product of AQ4N and it is formed under reducing
conditions on a mole for mole basis (Patterson, 1993). The
relatively long time interval (greater than 18 h) between
exposure to hypoxia and appearance of DNA toxicity
suggests that the active cytotoxic agent was not directly
damaging to the DNA but caused interference in the ability
of the cell to function. This is consistent with the evidence
that AQ4 (not AQ4N) causes topoisomerase II inhibition, a
process which interferes with cell cycle progression by
accumulation of cells in G2/M (Desnoyes et al., 1993; PJ
Smith, personal communication). The extent of damage
suggests a major disruption to cellular metabolism and may
even indicate that apoptosis is being initiated in compromised
cells. Previously Olive and Banath (1992) have shown that the
topoisomerase II inhibitor etoposide is much more toxic to
cycling cells than non-cycling cells. Our results are consistent
with their observation.
The oxygen-dependent cytotoxicity of AQ4N is lost within
24 h of tumour excision (Figure 3a-d) despite the evidence
of the drug being taken up into the cells. This observation
helps to explain the limited ability of established cell lines to
reduce AQ4N in vitro. It also suggests that in vitro testing of
chemotherapy drugs that require intratumoral enzymic
activation may on some occasions give misleading results,
since the enzyme profile (among other factors) may be
critically changed in the tissue culture environment. False-
positive and negative results may both result from this
phenomenon.
We have previously shown that AQ4N has bioreductive
potential in vivo (McAleer et al., 1992) and, when combined
with radiation, AQ4N shows an interaction that is at least
additive (McKeown et al., 1995). We therefore examined the
extent of DNA damage caused when AQ4N, with or without
radiation, was injected before tumour excision (Figure 4).
Control tumours showed little evidence of DNA damage
following excision. Also tumours treated with AQ4N alone
showed only a minimal number of damaged cells at any time
point examined. As expected a significant level of DNA
damage was observed in cells prepared from tumours excised
immediately after a single dose of radiation (Figure 4c).
Within 2 h, the level of measurable DNA damage was
reduced considerably and by 18 h only a few cells showed
any damage. This demonstrates that most of the damage
induced by radiation has been repaired within a short time.
When AQ4N is administered to tumour-bearing mice 30 min
before radiation, there is no appreciable difference in the
response of radiation-induced DNA damage over the first
18 h, suggesting that AQ4N had no appreciable effect on
radiation-induced damage and repair. However, by 24 h
plasma and tissue levels of AQ4N should be very low since
the half-life of the drug in mice is 30 min (Table I), despite
this there was an increase in DNA damage detectable from
24 to 120 h (Figure 4d), which was not seen with AQ4N
alone.
The results suggest that following the damage and
apparent repair of well-oxygenated cells by radiation there
is a requirement for repopulation of the tumour from viable
cells within the hypoxic fraction. Normally these cells would
not contribute to tumour growth, which explains the limited
effect on tumours treated with AQ4N alone. When the oxic
cells are sterilised by radiation treatment, the hypoxic cells
are reoxygenated and recruited into the cell cycle. At this
point the presence of a toxic insult to the cells would be
evident and the damage expressed. Our results support this
hypothesis and show that permanent damage occurs in the
hypoxic cells on exposure to AQ4N, which compromises their
ability to repopulate the tumour. Damaged cells increase in
number from 24 to 120 h after irradiation treatment,
suggesting that this effect is present in vivo for at least this
length of time. Since it is known that AQ4N can be reduced
under hypoxic conditions to the stable compound AQ4, one
explanation for the observed effect is the oxygen-dependent
production of the DNA-affinic metabolite AQ4, which
remains bound to the DNA in the hypoxic cells for many
hours/days. A further advantage of the production of a stable
DNA-affinic cytotoxic agent is the ability of the agents, once
generated, to kill cells at any level ofoxygenation. Even ifthe
drug diffuses from the original site of production its high
affinity for DNA will allow its effect to be exerted on
neighbouring cells.
In conclusion, this study shows that the cytotoxicity of
AQ4N is oxygen dependent and can affect T50/80 tumour
cells for at least 4 days after exposure to hypoxia. This is
consistent with the results of previous in vivo experiments
using tumour growth delay as the end point (McKeown et
al., 1995). The loss of the oxygen-dependent sensitivity to
AQ4N within 24 h of tumour excision provides evidence for
critical changes to tumour cell sensitivity following transfer to
culture. Use of the comet assay to immediately test excised
tumours with cytotoxic agents requiring in vivo metabolism
may provide a more appropriate method for determining in
vivo efficacy than the testing of putative cytotoxic agents
against panels of established tissue culture cell lines.
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